Elicio Therapeutics, Inc. (NASDAQ:ELTX) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Karen J. Wilson Other companies: Connect Biopharma Holdings Limited (Board Director · Since at least Mar 16, 2026); Serina Therapeutics, Inc. (Director · Since at least Jan 14, 2025); LAVA Therapeutics NV (Director · Since at least Jan 1, 2025); Vaxart, Inc. (Director · Aug 25, 2020 – Jun 16, 2021 · Past); Jazz Pharmaceuticals plc (SVP, Finance & PAO · Mar 9, 2011 – Mar 5, 2019 · Past) | Director · Since at least Feb 4, 2021 |
| Brian Piekos Other companies: KalVista Pharmaceuticals, Inc. (Chief Financial Officer · Since at least Sep 9, 2024); Disc Medicine, Inc. (CFO · Feb 12, 2021 – May 31, 2022 · Past); AMAG Pharmaceuticals Inc (Chief Financial Officer · Jun 9, 2020 – Nov 16, 2020 · Past) | Chief Financial Officer · Jun 1, 2023 – Feb 1, 2024 · Past |
| Jennifer J. Rhodes Other companies: ACADIA Pharmaceuticals Inc. (Chief Legal Officer and Secretary · Since at least Feb 6, 2024); Adamas Pharmaceuticals Inc (CBO, GC & Compliance Officer · Apr 11, 2016 – Jun 20, 2019 · Past); Medivation Inc (GC & Corporate Secretary · Mar 26, 2013 – Mar 16, 2015 · Past) | See Remarks · Feb 4, 2021 – Mar 2, 2022 · Past |
| Christopher Haqq Other companies: Surrozen, Inc. (Director · Nov 18, 2020 – Nov 18, 2020 · Past); Atara Biotherapeutics, Inc. (EVP, R&D & Chief Scientific Of · Oct 15, 2014 – Feb 15, 2019 · Past) | Executive Vice President, Head of Research and Development and Chief Medical Officer · Since at least Jun 1, 2023 |
| Gilbert S. Omenn Other companies: Amesite Inc. (Director · Since at least Sep 25, 2020); Galectin Therapeutics Inc. (Director · Since at least Dec 14, 2017) | Director · Feb 4, 2021 – Jun 9, 2022 · Past |
| Gregory S Curhan Other companies: Serina Therapeutics, Inc. (Chief Financial Officer · Since at least Aug 15, 2024); Power Efficiency Corporation (Director · Mar 11, 2009 – Mar 12, 2009 · Past) | See Remarks · Feb 4, 2021 – Mar 2, 2022 · Past |
| Jay Venkatesan Other companies: Serina Therapeutics, Inc. (Director · Since at least Feb 12, 2025); Alpine Immune Sciences Inc (Director · Jul 15, 2022 – Jul 15, 2022 · Past) | Director · Since at least May 20, 2022 |
| Julian Adams Other companies: Gamida Cell Ltd (Director · Jan 1, 2022 – Jan 31, 2024 · Past); Palvella Therapeutics, Inc. (Director · Jul 25, 2016 – Jan 25, 2018 · Past) | Chairman · Since at least Jun 1, 2023 |
| Preetam Shah Other companies: Cidara Therapeutics Inc (Chief Financial Officer · Sep 1, 2021 – Sep 30, 2024 · Past); Brainstorm Cell Therapeutics Inc. (EVP, CFO and Treasurer · Sep 6, 2019 – Dec 30, 2020 · Past) | Chief Strategy and Financial Officer · Since at least Mar 24, 2025 |
| Victor F. Ganzi Other companies: Aveanna Healthcare Holdings Inc. (Audit Committee Chair, Independent Director · Since at least Jun 30, 2022); Willis Towers Watson Public Limited Company (Director · May 11, 2022 – Jun 8, 2022 · Past) | Director · May 27, 2022 – Jun 9, 2022 · Past |
| Allen R. Nissenson Other companies: Rockwell Medical, Inc. (Director · Since at least Dec 11, 2020) | Director · Since at least Feb 4, 2021 |
| John F Neylan Other companies: Keryx Biopharmaceuticals Inc (Chief Medical Officer · Apr 22, 2015 – Dec 12, 2018 · Past) | See Remarks · Feb 4, 2021 – Mar 2, 2022 · Past |
| Yekaterina Chudnovsky Other companies: Immix Biopharma, Inc. (Independent Director · Since at least Aug 22, 2023) | Director · Since at least Jun 1, 2023 |
| Annette Matthies | Chief Business Officer · Jun 1, 2023 – Jun 1, 2023 · Past |
| Carol Ashe | Director · Since at least Nov 4, 2026 |
| Esther Welkowsky | Senior Vice President, Clinical Development · Since at least Nov 5, 2026 |
| Itzhak Goldberg | Director · Feb 4, 2021 – Jul 1, 2022 · Past |
| Joy Seymour | Senior Vice President, Head of Regulatory Affairs · Since at least Nov 5, 2026 |
| Marc Wolfgang | Chief Technology Officer · Since at least Nov 19, 2025 |
| Megan Filoon | General Counsel, Secretary and Compliance Officer · Since at least Nov 5, 2026 |
| Peter DeMuth | Chief Scientific Officer · Since at least Jun 1, 2023 |
| Robert Connelly | Chief Executive Officer · Since at least Jun 1, 2023 |
| Robert R. Ruffolo | Director · Since at least Nov 5, 2026 |
| Yekaterina Chudnovsky | Director · Since at least Nov 5, 2026 |